RT Journal Article
SR Electronic
T1 The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.17.21250449
DO 10.1101/2021.03.17.21250449
A1 Bosslet, Gabriel T.
A1 Pollak, Micah
A1 Jang, Jeong Hoon
A1 Roll, Rebekah
A1 Sperling, Mark
A1 Khan, Babar
YR 2021
UL http://medrxiv.org/content/early/2021/03/20/2021.03.17.21250449.abstract
AB Background To determine the county-level effect of in-person primary and secondary school reopening on daily cases of SARS-CoV-2 in Indiana.Methods This is a county-level population-based study using a panel data regression analysis of the proportion of in-person learning to evaluate an association with community-wide daily new SARS-CoV-2 cases. The study period was July 12-October 6, 2020. We included 73 out of 92 (79.3%) Indiana counties in the analysis, accounting for 85.7% of school corporations and 90.6% of student enrollement statewide. The primary exposure was the proportion of students returning to in-person instruction. The primary outcome was the daily new SARS-CoV-2 cases per 100,000 residents at the county level.Results There is a statistically significant relationship between the proportion of students attending K-12 schools in-person and the county level daily cases of SARS-CoV-2 28 days later. For all ages, the coefficient of interest (β) is estimated at 3.36 (95% CI: 1.91—4.81; p < 0.001). This coefficient represents the effect of a change the proportion of students attending in-person on new daily cases 28 days later. For example, a 10 percentage point increase in K-12 students attending school in-person is associated with a daily increase in SARS-CoV-2 cases in the county equal to 0.336 cases/100,000 residents of all ages.Conclusion In-person primary and secondary school is associated with a statistically significant but proportionally small increase in the spread of SARS-CoV-2 cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding for this work was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Per the Indiana University-Purdue University Indianapolis Institutional Review Board, this study was not subject to human subjects research oversight due to the lack of individual-level data collection.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, GB, upon reasonable request.